Paper Details
- Home
- Paper Details
Plasma concentrations of inhaled budesonide and its effects on plasma cortisol are increased by the cytochrome P4503A4 inhibitor itraconazole.
Author: KivistöKari T, NeuvonenMikko, NeuvonenPertti J, NiemiMikko, RaaskaKari
Original Abstract of the Article :
OBJECTIVE: Our objective was to examine the effects of itraconazole on the pharmacokinetics and cortisol-suppressant activity of budesonide administered by inhalation. METHODS: In a randomized, double-blind, 2-phase crossover study, 10 healthy subjects took 200 mg itraconazole or placebo orally onc...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1067/mcp.2002.127397
データ提供:米国国立医学図書館(NLM)
Itraconazole: A Potential Interaction with Inhaled Budesonide
This study investigates the interaction between [itraconazole], a potent inhibitor of [cytochrome P4503A4 (CYP3A4)], and [inhaled budesonide], a commonly used medication for [asthma] and other respiratory conditions. The researchers found that itraconazole significantly increased the systemic exposure to inhaled budesonide, potentially by inhibiting its metabolism via CYP3A4. This interaction resulted in enhanced systemic effects of budesonide, leading to increased suppression of cortisol production. The study highlights the importance of considering potential drug interactions when prescribing medications, especially those metabolized by CYP3A4.
Itraconazole: A Cautionary Tale of Drug Interactions
The study underscores the importance of considering drug interactions, particularly when co-administering medications metabolized by CYP3A4. The findings suggest that itraconazole can significantly increase the systemic exposure to inhaled budesonide, potentially leading to enhanced systemic effects and increased suppression of cortisol production. This highlights the potential risk of adverse effects associated with long-term co-administration of budesonide and CYP3A4 inhibitors.
Drug Interactions: A Navigational Challenge in Healthcare
Navigating the complex landscape of drug interactions is a crucial aspect of healthcare. This study provides a valuable reminder of the potential consequences of co-administering medications that interact with each other. Understanding these interactions is essential for ensuring patient safety and optimizing treatment outcomes. It is important to always consult a healthcare professional to determine the best treatment plan for individual needs.
Dr.Camel's Conclusion
Imagine two different types of desert plants: one plant thrives on water, while the other thrives on drought. Similarly, itraconazole and inhaled budesonide interact in a way that can alter their individual effects. This study highlights the importance of understanding how medications interact, just like understanding how different desert plants thrive in different conditions. It's a reminder that we must be mindful of these interactions to ensure a safe and effective journey through the desert of medicine.
Date :
- Date Completed 2002-11-12
- Date Revised 2018-12-11
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.